Real-World study checks eczema drug safety in teens
NCT ID NCT05029895
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the safety and effectiveness of the eczema drug upadacitinib in teenagers aged 12 to under 18 in Japan. About 170 teens who were already prescribed the drug by their doctor took part. Researchers collected data from regular clinic visits and questionnaires over about 2 years to see how well the drug works and what side effects occur in everyday use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
167 people
The number who actually took part.
- Started
-
Sep 2021
- Finished
-
Sep 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adolescent participants receiving upadacitinib according to the product prescribing information for atopic dermatitis in Japan.
- Ages
-
12 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants who are diagnosed with atopic dermatitis (AD). * History of topical anti-inflammatory agents such as topical steroids and topical tacrolimus for AD. * Participants initiating upadacitinib for the treatment of AD in routine clinical practice. * Body weight \>=30 kg at the start of dosing. Exclusion Criteria: * Prior treatment with upadacitinib * Currently participating in another registrational clinical research study * Participants for whom upadacitinib is contraindicated
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atopic dermatitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aichi Children's Health and Medical Center /ID# 245357
Obu-shi, Aichi-ken, 474-8710, Japan
-
Aso Iizuka Hospital /ID# 252145
Iizuka-shi, Fukuoka, 820-8505, Japan
-
Bito Dermatology Clinic /ID# 244093
Kobe, Hyōgo, 651-0095, Japan
-
Central Japan International Medical Center /ID# 246625
Minokamo-shi, Gifu, 505-8510, Japan
-
Chutoen General Medical Center /Id# 248741
Kakegawa-shi, Shizuoka, 436-0040, Japan
-
Chutoen General Medical Center /Id# 249522
Kakegawa-shi, Shizuoka, 436-0040, Japan
-
Dokkyo Medical University Hospital /ID# 245068
Mibu, Tochigi, 321-0293, Japan
-
Dokkyo Medical University Saitama Medical Center /ID# 249525
Koshigaya, Saitama, 343-0845, Japan
-
Duplicate_Japanese Red Cross Osaka Hospital /ID# 249524
Osaka, Osaka, 543-8555, Japan
-
Duplicate_Kobayashi Skin Clinic /ID# 248006
Sapporo, Hokkaido, 060-0807, Japan
-
Fraternity Memorial Hospital /ID# 245974
Sumida-ku, Tokyo, 130-8587, Japan
-
Fukuoka Children'S Hospital /ID# 245067
Fukuoka, 813-0017, Japan
-
Hayano Pediatrician Clinic /ID# 250960
Himeji-shi, Hyōgo, 679-2151, Japan
-
Hino Clinic /ID# 245975
Sakai-shi, Osaka, 599-8272, Japan
-
Hiratsuka City Hospital /ID# 245071
Hiratsuka-shi, Kanagawa, 254-0065, Japan
-
Hiroshima University Hospital /ID# 245356
Hiroshima, Hiroshima, 734-8551, Japan
-
Hoshi General Hospital /ID# 250959
Koriyama-shi, Fukushima, 963-8501, Japan
-
Hosui General Medical Clinic /ID# 241881
Sapporo, Hokkaido, 060-0063, Japan
-
Ichinomiya Municipal Hospital /ID# 245070
Ichinomiya-shi, Aichi-ken, 491-8558, Japan
-
Imamura General Hospital /ID# 249526
Kagoshima, Kagoshima-ken, 890-0064, Japan
-
Kagoshima City Hospital /ID# 252142
Kagoshima, Kagoshima-ken, 673-0886, Japan
-
Kagoshima University Hospital /ID# 248732
Kagoshima, Kagoshima-ken, 890-8520, Japan
-
Kanagawa Children's Medical Center /ID# 252144
Yokohama, Kanagawa, 232-8555, Japan
-
Kansai Medical University Hospital /ID# 246020
Hirakata-shi, Osaka, 573-1191, Japan
-
Kansai Medical University Takii Hospital /ID# 250195
Moriguchi, Osaka, 570-8507, Japan
-
Kitami Red Cross Hospital /ID# 250838
Kitami-shi, Hokkaido, 090-0026, Japan
-
Kobe City Medical Center General Hospital /ID# 244052
Kobe, Hyōgo, 650-0047, Japan
-
Kobe City Medical Center General Hospital /ID# 250836
Kobe, Hyōgo, 650-0047, Japan
-
Kurume University Hospital /ID# 248740
Kurume-shi, Fukuoka, 830-0011, Japan
-
Maekawa Kids Clinic /ID# 249521
Sichuan, Hyōgo, 666-0017, Japan
-
Matsuyama Red Cross Hospital /ID# 248739
Matsuyama, Ehime, 790-8524, Japan
-
Mito Kyodo General Hospital /ID# 243745
Mito, Ibaraki, 310-0015, Japan
-
NHO Nagoya Medical Center /ID# 245069
Nagoya, Aichi-ken, 460-0001, Japan
-
Nagahama Red Cross Hospital /ID# 252136
Nagahama-shi, Shiga, 526-8585, Japan
-
Nagoya City University Hospital /ID# 250809
Nagoya, Aichi-ken, 467-8602, Japan
-
Naha City Hospital /ID# 245065
Naha, Okinawa, 902-0061, Japan
-
National Center For Child Health And Development /ID# 244696
Setagaya City, Tokyo, 157-8535, Japan
-
National Hospital Organization Sagamihara National Hospital /ID# 243744
Sagamihara-shi, Kanagawa, 252-0392, Japan
-
National Hospital Organization Shimoshizu National Hospital /ID# 245064
Yotsukaido-shi, Chiba, 284-0003, Japan
-
National Mie Hospital /ID# 245066
Tsu, Mie-ken, 514-0125, Japan
-
Nippon Medical Chiba Hokusoh Hospital /ID# 246627
Inzai-shi, Chiba, 270-1613, Japan
-
Noriko Dermatology Clinic /ID# 246626
Akita, Akita, 010-0062, Japan
-
Okada Kodomonomori Clinic /ID# 248096
Kasukabe-shi, Saitama, 344-0011, Japan
-
Okayama University Hospital /ID# 252141
Okayama, Okayama-ken, 700-8558, Japan
-
Osaka Medical and Pharmaceutical University Hospital /ID# 251660
Takatsuki-shi, Osaka, 569-8686, Japan
-
Osaka Metropolitan University Hospital /ID# 245972
Osaka, Osaka, 545-8586, Japan
-
Saitama Medical Center /ID# 244695
Kawagoe, Saitama, 350-8550, Japan
-
Shiga University of Medical Science Hospital /ID# 245969
Ōtsu, Shiga, 520-2192, Japan
-
Sugamo Sengoku Dermatology /ID# 247761
Toshima City, Tokyo, 170-0002, Japan
-
Suzuki Kids Clinic /ID# 243743
Shingū, Wakayama, 647-0042, Japan
-
Takagi Dermatological Clinic /ID# 241160
Obihiro-Shi, Hokkaido, 080-0013, Japan
-
Takatsuki General Hospital /ID# 242334
Osaka, Japan
-
Takeo Skin Clinic /ID# 248095
Asahi Owari, Aichi-ken, 488-0032, Japan
-
Takeoka Dermatology Clinic /ID# 240610
Marugame, Kagawa-ken, 763-0074, Japan
-
Teikyo University Mizonokuchi Hospital /ID# 252146
Kawasaki, Kanagawa, 213-8507, Japan
-
Tokyo Med Univ Hachioji Med Ct /ID# 250958
Hachioji-shi, Tokyo, 193-0998, Japan
-
Tokyo Metropolitan Hiroo Hospital /ID# 250837
Shibuya Ward, Tokyo, 150-0013, Japan
-
Tonami General Hospital /ID# 247760
Tonami-shi, Toyama, 939-1395, Japan
-
Torii Dermatology Clinic /ID# 252143
Nonoichi-shi, Ishikawa-ken, 921-8821, Japan
-
Wakayama Medical University Hospital /ID# 247498
Wakayama, Wakayama, 641-8510, Japan
-
Yamaguchi Grand Medical Center /ID# 251659
Hohu-shi, Yamaguchi, 747-8511, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Skin scans may predict who responds to dupilumab for eczema
- Can a daily liquid medicine calm severe eczema in toddlers and preschoolers?
- Scientists probe whether lebrikizumab rewires diseased skin at the molecular level
- Can a Lab-Made antibody calm severe eczema?
- Is your nose fueling infected eczema and scabies sores?
- Can an eczema drug reshape the Skin's microbial community?